Clinical trial
Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting
NCT02977741 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting
- Lead sponsor
- Johns Hopkins University
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- November 30, 2016
- Completion date
- December 31, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.